Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study.
Saved in:
| Title: | Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study. |
|---|---|
| Authors: | Durongpisitkul, Kritvikrom1 (AUTHOR) kritvikrom.dur@mahidol.ac.th, Chungsomprasong, Paweena1 (AUTHOR), Vijarnsorn, Chodchanok1 (AUTHOR), Chanthong, Prakul1 (AUTHOR), Kanjanauthai, Supaluck1 (AUTHOR), Soongswang, Jarupim1 (AUTHOR) |
| Source: | JRSM Cardiovascular Disease. 1/21/2021, Vol. 10, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
